HomeCompareTSVT vs O

TSVT vs O: Dividend Comparison 2026

TSVT yields 40.00% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TSVT wins by $197.6K in total portfolio value
10 years
TSVT
TSVT
● Live price
40.00%
Share price
$5.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$231.9K
Annual income
$39,181.04
Full TSVT calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — TSVT vs O

📍 TSVT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTSVTO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TSVT + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TSVT pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TSVT
Annual income on $10K today (after 15% tax)
$3,400.00/yr
After 10yr DRIP, annual income (after tax)
$33,303.88/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, TSVT beats the other by $28,966.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TSVT + O for your $10,000?

TSVT: 50%O: 50%
100% O50/50100% TSVT
Portfolio after 10yr
$133.1K
Annual income
$22,141.89/yr
Blended yield
16.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

TSVT
Analyst Ratings
4
Buy
6
Hold
Consensus: Hold
Price Target
$3.50
-30.0% upside vs current
Range: $2.00 — $5.00
Altman Z
-1.0
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TSVT buys
0
O buys
0
No recent congressional trades found for TSVT or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTSVTO
Forward yield40.00%5.28%
Annual dividend / share$2.00$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$231.9K$34.2K
Annual income after 10y$39,181.04$5,102.74
Total dividends collected$174.4K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$3.50$64.00

Year-by-year: TSVT vs O ($10,000, DRIP)

YearTSVT PortfolioTSVT Income/yrO PortfolioO Income/yrGap
1← crossover$14,700$4,000.00$10,818$608.16+$3.9KTSVT
2$21,224$5,495.33$11,787$741.68+$9.4KTSVT
3$30,125$7,415.26$12,946$911.00+$17.2KTSVT
4$42,071$9,836.48$14,345$1,127.94+$27.7KTSVT
5$57,854$12,838.17$16,056$1,409.05+$41.8KTSVT
6$78,403$16,499.54$18,171$1,777.83+$60.2KTSVT
7$104,788$20,897.28$20,820$2,268.21+$84.0KTSVT
8$138,226$26,102.79$24,188$2,929.90+$114.0KTSVT
9$180,082$32,179.61$28,533$3,837.11+$151.5KTSVT
10$231,869$39,181.04$34,235$5,102.74+$197.6KTSVT

TSVT vs O: Complete Analysis 2026

TSVTStock

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

Full TSVT Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this TSVT vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TSVT vs SCHDTSVT vs JEPITSVT vs KOTSVT vs MAINTSVT vs STAGTSVT vs ADCTSVT vs NNNTSVT vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.